Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Zoom Video Communications, Inc. (ZM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Zoom Video Communications, Inc. — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Zoom Video Communications, Inc. trades at $94.9 (market cap $27.65B). The key difference: Zoom Video Communications, Inc. is far larger — about 16.2× Nuvation Bio Inc. Class A Common Stock's market cap, and Zoom Video Communications, Inc. is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Zoom Video Communications, Inc. for 92 Days on average.
| NUVB | ZM | |
|---|---|---|
Market Cap | $1.71B | $27.65B |
Volume | 5,448,712 | 2,342,017 |
Sector | Health | Technology |
52-Week High | $9.54 | $111.88 |
52-Week Low | $3.41 | $72.72 |
Typical Hold Time | 0 Days | 92 Days |
Enterprise Value | $1.30B | $20.46B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zoom Communications (ZM) trades at $94.77, up 0.61% today, with a bullish technical signal supported by moving averages. The company reported strong profitability with a net income margin of 65.19% and ROE of 32.14% for 2026. Recent earnings beats in Q1 and Q2 2026, alongside AI-driven product launches like the Revenue OS, highlight growth momentum. Analyst consensus is a Buy with a $118.08 price target, though mixed sentiment persists with 55.1% Hold ratings.
The outlook for ZM is positive, driven by AI integration and earnings strength, but risks include reliance on international sales and competitive pressures. Upside potential exists if the company meets Q3 2026 EPS expectations of $1.50, though volatility near resistance at $95-$97 may challenge short-term gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Zoom Video Communications, Inc.
Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →
